Stifel Financial Corp Alnylam Pharmaceuticals, Inc. Transaction History

Stifel Financial Corp

$86.8 Billion
Q2 2024

A detailed history of Stifel Financial Corp transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 5,939 shares of ALNY stock, worth $1.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,939

Previous 8,340 28.79%

Holding current value

$1.59 Million

Previous $1.25 Million 15.81%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$143.31 - $247.0 $344,087 - $593,047	-2,401 Reduced 28.79%	5,939 $1.44 Million
Q1 2024 May 13, 2024	SELL	$146.51 - $198.2 $486,120 - $657,627	-3,318 Reduced 28.46%	8,340 $1.25 Million
Q4 2023 Feb 12, 2024	BUY	$151.41 - $196.57 $543,410 - $705,489	3,589 Added 44.48%	11,658 $2.23 Million
Q3 2023 Nov 13, 2023	SELL	$170.77 - $211.65 $213,974 - $265,197	-1,253 Reduced 13.44%	8,069 $1.43 Million
Q2 2023 Aug 14, 2023	BUY	$185.01 - $212.05 $298,051 - $341,612	1,611 Added 20.89%	9,322 $1.77 Million
Q1 2023 May 12, 2023	BUY	$182.66 - $235.53 $47,674 - $61,473	261 Added 3.5%	7,711 $1.54 Million
Q4 2022 Feb 13, 2023	SELL	$185.53 - $241.31 $520,782 - $677,357	-2,807 Reduced 27.37%	7,450 $1.77 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $93,237 - $156,136	673 Added 7.02%	10,257 $2.05 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $312,128 - $438,799	-2,592 Reduced 21.29%	9,584 $1.4 Million
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $317,950 - $434,775	-2,500 Reduced 17.03%	12,176 $1.99 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $107,543 - $141,061	674 Added 4.81%	14,676 $2.49 Million
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $1.49 Million - $1.82 Million	-8,775 Reduced 38.53%	14,002 $2.64 Million
Q2 2021 Aug 13, 2021	BUY	$128.63 - $176.89 $325,433 - $447,531	2,530 Added 12.5%	22,777 $3.86 Million
Q1 2021 May 14, 2021	BUY	$126.83 - $175.69 $533,573 - $739,127	4,207 Added 26.23%	20,247 $2.86 Million
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $161,090 - $192,570	1,310 Added 8.89%	16,040 $2.08 Million
Q3 2020 Nov 16, 2020	BUY	$121.19 - $165.49 $156,092 - $213,151	1,288 Added 9.58%	14,730 $2.14 Million
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $741,558 - $1.11 Million	7,116 Added 112.49%	13,442 $1.99 Million
Q1 2020 May 14, 2020	BUY	$93.12 - $133.99 $152,623 - $219,609	1,639 Added 34.97%	6,326 $689,000
Q4 2019 Feb 13, 2020	BUY	$74.51 - $124.23 $44,929 - $74,910	603 Added 14.76%	4,687 $539,000
Q3 2019 Nov 13, 2019	BUY	$70.9 - $87.82 $8,082 - $10,011	114 Added 2.87%	4,084 $328,000
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $98,526 - $138,813	1,496 Added 60.47%	3,970 $288,000
Q1 2019 May 14, 2019	BUY	$72.76 - $93.45 $180,008 - $231,195	2,474 New	2,474 $232,000

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Alnylam Pharmaceuticals, Inc. Transaction History